Position in HROW
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$312,409
+$38,862 QoQ
Shares Held
7,356
-5.2% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#132
of 223 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026IHT Wealth Management, LLC holds $5,402,284 across 6 Drug Manufacturers - Specialty & Generic names. HROW ranks #4 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XERS |
Xeris Biopharma Holdings, Inc.
|
481,871 | $3,816,418 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
15,520 | $538,078 | |
| 3 | VTRS |
Viatris Inc
|
25,921 | $411,625 | |
| 4 | HROW |
Harrow, Inc.
This page
|
7,356 | $312,409 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,115 | $207,176 | |
| 6 | HLN |
Haleon plc
|
12,495 | $116,578 |
All Filings in HROW
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $312,409 | 7,356 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $273,547 | 7,758 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||